Specific allergen immunotherapy: time for alternatives?
- 1 January 2002
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 32 (1) , 1-3
- https://doi.org/10.1046/j.0022-0477.2001.01278.x
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Sublingual‐swallow immunotherapy (SLIT) in patients with asthma due to house‐dust mites: a double‐blind, placebo‐controlled studyAllergy, 1999
- Local immunotherapyAllergy, 1998
- Long‐term follow‐up of nasal immunotherapy to Parietaria: clinical and local immunological effectsClinical and Experimental Allergy, 1997
- Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) studyClinical and Experimental Allergy, 1996
- Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: A double-blind studyJournal of Allergy and Clinical Immunology, 1996
- A double‐blind, placebo‐controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extractAllergy, 1994
- Local immunotherapy is not documented for clinical useAllergy, 1994
- A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patientsClinical and Experimental Allergy, 1994
- Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice.The Journal of Experimental Medicine, 1993
- Local nasal immunotherapy for Dermatophagoides-induced rhinitis: Efficacy of a powder extractJournal of Allergy and Clinical Immunology, 1993